Info

Genovo, Inc., is a privately-held biotechnology company focusing on the design, and early stage clinical development of gene-based therapeutic products for the treatment of human disease. Genovo's product development pipeline includes its internal programs for hyperlipidemia, atherosclerosis, hemophilia, and wound healing as well as strategic partnerships with Genzyme General to develop gene therapy for lysosomal storage disorders and Biogen, Inc., to develop gene therapy applications for liver and lung diseases and cancer. Genovo's technology platform includes over 145 issued patents and patent applications covering gene therapy vectors, manufacturing, and methods of use.